Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/2002
10/16/2002CN1092712C Process for producing human C36/C46 receptor (CR1) polypeptide
10/16/2002CN1092652C 2-imidazolinylaminoindole compound and composition containing the same use
10/16/2002CN1092649C Thiazolidinone compounds or angina pectoris curing or preventing agent with the same as active ingredient
10/16/2002CN1092641C Preparation for medicine containing substituted pyridyl-dihydroxy-heptenonic acid or its salts
10/16/2002CA2406198A1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
10/16/2002CA2406161A1 2-guanidino-4-arylquinazolines as nhe-3 inhibitors
10/15/2002US6465715 Dna fragments from the promoter region of the c. elegans ul6 gene which are capable of functioning as promoters directing gene expression in the excretory cell of c. elegans are provided and also expression vectors and transgenic c. elegans
10/15/2002US6465687 Thyroid receptor ligands and method
10/15/2002US6465660 Isoindoloindolone compounds
10/15/2002US6465518 2-amino-5-fluoro-6-(1-iminoethylamino)-hept-4-enoic acid, for example; treating or preventing various causes of inflammation
10/15/2002US6465516 Increasing nitric oxide production by administering inhibitors of hmg-coa-reductase; treatment of diseases related to endothelial dysfunction
10/15/2002US6465513 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
10/15/2002US6465500 Indole derivatives as 5-HT1 agonists
10/15/2002US6465497 Arylthiazolidinedione derivatives
10/15/2002US6465493 Such as 4-(4-(4-fluorophenyl)-5-(2-pyridyl)-1-hydroxy-1h-imidazol-2-yl)benzonitrile; alk5 mediated diseases such as arthritis, osteoporosis, kidney and renal diseases, conges-tive heart failure, ulcers, diabetic nephropathy
10/15/2002US6465491 6-phenylpyridyl-2-amine derivatives
10/15/2002US6465483 Treating or preventing strokes; chronic inflammatory disorders such as bronchial asthma and arthritis; antiproliferative effect; ulcerative colitis and crohn's disease
10/15/2002US6465481 Exhibit electrophysiological activity; may be more potent and produce fewer side effects including lower incidence of proarrhythmias such as torsades de pointes
10/15/2002US6465478 Analgesics, antiinflammatories, diuretics, anesthetics, neuroprotective agents, antihypertensive or antianxiety agent, appetite control, hearing regulation
10/15/2002US6465472 Substituted quinazolines and analogs and use thereof
10/15/2002US6465468 Hydroxamic and carboxylic acid derivatives
10/15/2002US6465454 Combinations of statins and estrogenic agents
10/15/2002US6465451 Hypolipidemic benzothiazepine compounds
10/15/2002US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
10/15/2002US6465444 Protein tyrosine phosphatases(ptp-1b); antidiabetic, antitumor and anorexigenic agents; combination therapy
10/15/2002US6465424 Comprising a purified polypeptide the amino acid sequence of which comprises the pre-activation domain from plasminogen and at least one kringle from plasminogen
10/15/2002US6465007 Gene therapy using absorption enhancers or tight junction disrupters; transfection of a biologically active molecule by a cationic amphiphile: biologically active molecule complex or other lipid or viral or nonviral vectors; cystic fibrosis
10/15/2002US6465003 Drug delivery
10/15/2002CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
10/15/2002CA2145211C The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
10/15/2002CA2112690C Amino acid derivative
10/15/2002CA2091766C Enhancement of glutathione levels with glutamine
10/15/2002CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments
10/15/2002CA2063521C Tacky, hydrophilic gel dressings and products therefrom
10/15/2002CA2038985C Haloethyl-substituted steroidal enzyme inhibitors
10/10/2002WO2002079778A2 In vivo delivery methods and compositions
10/10/2002WO2002079478A2 Modification of organelle metabolism by a composition comprising unc-51-like kinases, roma1, or 2tm polypeptides and uses thereof for the preration of a medicament for the treatment disorders
10/10/2002WO2002079456A2 A method for the preparation of immunologically inert amniotic membranes
10/10/2002WO2002079448A2 G-protein coupled receptors
10/10/2002WO2002079441A2 Secreted proteins
10/10/2002WO2002079408A2 Short bioactive peptides and methods for their use
10/10/2002WO2002079404A2 Cytoskeleton-associated proteins
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002WO2002079238A2 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
10/10/2002WO2002079221A2 Sapogenin derivatives, their synthesis and use
10/10/2002WO2002079204A1 8-thiazolyl[1,2,4]triazolo[1,5-c]pyrimidine derivative
10/10/2002WO2002079198A1 Pyridazinone aldose reductase inhibitors
10/10/2002WO2002079197A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/10/2002WO2002079196A1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor
10/10/2002WO2002079195A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/10/2002WO2002079188A1 Pyrrolidine sulfonamides
10/10/2002WO2002079169A1 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079158A1 Novel amlodipine camsylate and method for preparing thereof
10/10/2002WO2002079156A1 Novel piperidine derivatives as modulators of chemokine receptor
10/10/2002WO2002079155A1 Pyrrolidine sulfonamides
10/10/2002WO2002079154A1 Substituted carbazoles as inhibitors of spla2
10/10/2002WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
10/10/2002WO2002079149A2 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
10/10/2002WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
10/10/2002WO2002079139A1 Conjugated unsaturated glyceride mixtures and a method for producing the same
10/10/2002WO2002078747A2 Pregabalin lactose conjugates
10/10/2002WO2002078738A1 Blood rheology improving agents
10/10/2002WO2002078725A1 Biologically active chloroform fraction of an extract obtained from a mangrove plant salvadora persica l
10/10/2002WO2002078718A2 Compositions, methods and apparatuses for singlet oxygen delivery
10/10/2002WO2002078707A1 Pyrrolidine sulfonamides
10/10/2002WO2002078705A1 Hsp inductor
10/10/2002WO2002078699A1 Compounds and methods
10/10/2002WO2002078697A1 Compounds and methods
10/10/2002WO2002078696A1 Compounds and methods
10/10/2002WO2002078692A1 Method of treatment
10/10/2002WO2002078685A1 Drugs for vascular lesion
10/10/2002WO2002078684A2 Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
10/10/2002WO2002078682A2 Estrogen replacement therapy
10/10/2002WO2002078680A1 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye
10/10/2002WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors
10/10/2002WO2002078641A2 Pyrrolidine sulfonamides
10/10/2002WO2002078639A2 A method of treating proliferative diseases using eg5 inhibitors
10/10/2002WO2002078626A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078625A2 Therapeutic combinations for cardiovascular and inflammatory indications
10/10/2002WO2002078623A2 Uses of targeted oxidative therapeutic formulation in arteriosclerosis
10/10/2002WO2002078615A2 Antioxidant nitroxides and nitrones as therapeutic agents
10/10/2002WO2002078605A2 Premixed amiodarone parenteral solution and method for making the same
10/10/2002WO2002078600A2 γεRACK PEPTIDE COMPOSITION AND METHOD FOR PROTECTION AGAINST TISSUE DAMAGE DUE TO ISCHEMIA
10/10/2002WO2002078468A1 Food or beverage for vascular disorder or disease
10/10/2002WO2002062795A9 Dihydropyrazolopyridine compounds and pharmaceutical use thereof
10/10/2002WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002WO2002051460A3 Bioactive materials for aneurysm repair
10/10/2002WO2002050067A3 Pharmaceutical heterocyclic compounds
10/10/2002WO2002046373A8 Method of collecting placental stem cells
10/10/2002WO2002041881A3 Repinotan kit
10/10/2002WO2002041827A3 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
10/10/2002WO2002032406A3 Methods and products related to pulmonary delivery of polysaccharides
10/10/2002WO2002024706A3 Water soluble rapamycin esters
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002013809A3 Compositions containing hypotriglyceridemically active stilbenoids
10/10/2002WO2002008389A3 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001095895A3 Methods of potentiating organic nitrates having vasodilating activity and formulations for the same
1 ... 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 ... 1595